Study on prediction of relapse of rheumatoid arthritis after discontinuation of bDMARD

Study on prediction of relapse of rheumatoid arthritis after discontinuation of bDMARD - Study on prediction of relapse of rheumatoid arthritis after discontinuation of bDMARD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044434

Enrollment

Registered

2021-06-04

Start date

2010-02-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rheumatoid arthritis patients who have agreed to discontinue bDMARD with DAS28-CRP maintained below 2.3 for more than 1 year

Exclusion criteria

Exclusion criteria: Patients who do not agree to discontinue bDMARD

Design outcomes

Primary

Measure	Time frame
Percentage of low disease activity or higher within a 2-year observation period after discontinuation of bDMARD	—

Countries

Japan

Contacts

Public ContactKatsuya Nagatani

Jichi Medical University Division of Rheumatology and Clinical Immunology, Department of Medicine

knagatani@jichi.ac.jp0285-58-7358

Outcome results